KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BPTH
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Bio-Path Holdings stock price on Friday moving between $2.50 and $2.78
(Updated on Apr 26, 2024)

Sell candidate since Apr 22, 2024 Loss -8.22% PDF

The Bio-Path Holdings stock price gained 1.71% on the last trading day (Friday, 26th Apr 2024), rising from $2.64 to $2.68. During the last trading day the stock fluctuated 11.20% from a day low at $2.50 to a day high of $2.78. The price has risen in 6 of the last 10 days but is still down by -12.13% for this period. Volume fell on the last day by -39 thousand shares and in total, 117 thousand shares were bought and sold for approximately $313.81 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.54 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 58.03% during the next 3 months and, with a 90% probability hold a price between $4.02 and $12.94 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BPTH Signals & Forecast

There are few to no technical positive signals at the moment. The Bio-Path Holdings stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.13 and $4.02. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, March 06, 2024, and so far it has fallen -58.39%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Bio-Path Holdings stock

Bio-Path Holdings finds support from accumulated volume at $2.64 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.280 between high and low, or 11.20%. For the last week the stock has had daily average volatility of 17.75%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BPTH) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Bio-Path Holdings to open at $2.65, and during the day (based on 14 day Average True Range), to move between $1.97 and $3.39, which gives a possible trading interval of +/-$0.709 (+/-26.44%) up or down from last closing price. If Bio-Path Holdings takes out the full calculated possible swing range there will be an estimated 52.88% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.69 (0.19%) than the support at $2.64 (1.68%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Bio-Path Holdings stock A Buy?

The Bio-Path Holdings stock holds several negative signals and despite the positive trend, we believe Bio-Path Holdings will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.893 Sell Candidate Unchanged

Predicted Opening Price for Bio-Path Holdings of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$2.65 ( 1.00%) $2.68

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BPTH

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.93 9.45 %
R2 2.83 5.46 %
R1 2.76 3.00 %
Current price: 2.68
Support S1 2.55 -4.99 %
S2 2.48 -7.45 %
S3 2.37 -11.44 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.24 20.90 %
R2 2.92 8.96 %
R1 2.69 0.187 %
Current price 2.68
Support S1 2.64 -1.68%
S2 2.49 -7.09%
S3 0 .

FAQ

What is the symbol for Bio-Path Holdings Stock and on which exchange is it traded?
The symbol for Bio-Path Holdings is BPTH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Bio-Path Holdings Stock?
The Bio-Path Holdings stock holds several negative signals and despite the positive trend, we believe Bio-Path Holdings will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Bio-Path Holdings Stock?
Bio-Path Holdings Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Bio-Path Holdings Stock.

What's the current price of Bio-Path Holdings Stock?
As of the end of day on the Apr 26, 2024, the price of an Bio-Path Holdings (BPTH) share was $2.68.

What is the 52-week high and low for Bio-Path Holdings Stock?
The 52-week high for Bio-Path Holdings Stock is $7.67 and the 52-week low is $0.320.

What is the market capitalization of Bio-Path Holdings Stock?
As of the Apr 26, 2024, the market capitalization of Bio-Path Holdings is 4.195M.

When is the next earnings date for Bio-Path Holdings?
The upcoming earnings date for Bio-Path Holdings is May 10, 2024.
Click to get the best stock tips daily for free!

About Bio-Path Holdings

Bio-Path Holdings Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials f... BPTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT